Condition

Malignant Tumors clinical trials and research

• 7Clinical trials
• 2Countries

Newest Malignant Tumors clinical trials

All recruiting trials (7)

• Prognosis and molecular features of malignant tumors in adults

  This study tests how key molecular features relate to outcomes in adults with malignant tumors treated at a single hospital.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07622667

• 68Ga-FL-031 PET for diagnosing and staging cancer

  This project will test whether 68Ga-FL-031 PET imaging, compared with 18F-FDG PET, can detect and stage small cell lung cancer, breast cancer, nasopharyngeal carcinoma and other tumors in adults.

  Recruiting Early Phase 1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07301801

• LM-350 treatment for advanced solid tumors

  This trial will test LM-350, an experimental injectable drug, in adults with advanced solid tumors who have not responded to or cannot receive standard treatments.

  Recruiting at 3 sites Phase 1/2 LaNova Medicines Limited · Wollongong, New South Wales and 3 other locations · NCT07112222

• mRNA vaccine targeting KRAS-mutated cancers

  We will try an mRNA vaccine that targets KRAS mutations in adults with KRAS-mutated solid tumors, given alone or with the immunotherapy drug toripalimab and/or standard chemotherapy.

  Recruiting Phase 1 Sichuan University · Chengdu, Sichuan · NCT07004244

• Testing SSS59 for advanced malignant tumors

  This study is testing a new treatment called SSS59 to see if it is safe and effective for people with advanced cancer.

  Recruiting Phase 1 Shenyang Sunshine Pharmaceutical Co., LTD. · Shanghai, Shanghai Municipality · NCT06944444

• Testing LM-299 for advanced malignant tumors

  This study is testing a new treatment called LM-299 to see if it is safe and can help people with advanced solid tumors that haven't responded to other therapies.

  Recruiting Phase 1/2 LaNova Medicines Limited · Perth, Western Australia and 5 other locations · NCT06650566

• Testing LM-101 Injection for Advanced Malignant Tumors

  This study is testing a new injection called LM-101 to see if it is safe and effective for people with advanced malignant tumors, both on its own and with other treatments.

  Recruiting at 3 sites Phase 1/2 LaNova Medicines Limited · Guangzhou, Guangdong and 4 other locations · NCT05615974

Related topics

Quick answers

How many Malignant Tumors clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (7 trials), Australia (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 1: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →